Results 41 to 50 of about 7,983,647 (299)

Survival outcomes of locally advanced gastric cancer cases with pathological complete response received neoadjuvant chemotherapy

Precision Medical Sciences, 2021
Objective The aim of this study is to explore the survival situation of locally advanced gastric cancer (GC) patients with pathological complete response (pCR) following neoadjuvant chemotherapy (NAC).
Qing Hu, Jian Wang, Wei‐Guo Xu, Peng Shao, Gang Li   +4 more
doaj   +1 more source

Pathological complete response in pancreatic adenocarcinoma with FOLFIRINOX

BMJ Case Reports, 2018
The report describes a patient who presented to our centre with abdominal pain and significant weight loss due to adenocarcinoma of the tail of the pancreas. The cancer was deemed as ‘resectable disease associated with morbid surgical outcomes’ due to the local involvement of the vessels and adjacent organs.
Chien-Ting Kao, Muhammad Aziz, Anup Kasi
openaire   +3 more sources

The effect of tislelizumab on complete and pathological complete response in non-small cell lung cancer: a systematic review and meta-analysis

Frontiers in Oncology
BackgroundImmune checkpoint inhibitors have transformed non-small cell lung cancer (NSCLC) treatment, and while overall survival (OS) and progression-free survival (PFS) are well-established, a comprehensive meta-analysis focusing on complete response ...
Qian Feng, Xiaoxia Yan, Liping Gao, Hui Li, Baik Sarah, Russo Anna, Hongying Jiang   +6 more
doaj   +1 more source

Pathological complete response.

, 2015
Pathological complete response.
Muneharu Konishi (833445), Kazuhiko Yamagami (833443), Daishu Miura (833440), Tomoyuki Kubota (833449), Yoshie Hasegawa (394398), Seung Jin Kim (833442), Takashi Ishikawa (206896), Masaru Miyashita (833444), Masato Suzuki (833447), Yasushi Shigeoka (833446), Jun Horiguchi (833439), Tetsuya Taguchi (833448), Hirokazu Tanino (833438), Norio Kohno (833450), Shintaro Takao (833441), Mitsuhiro Hayashi (679464), Kouhei Akazawa (15187)   +16 more
core   +1 more source

Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial

, 2021
PURPOSE: Intrauterine levonorgestrel (LNG-IUD) is used to treat patients with endometrial adenocarcinoma (EAC) and endometrial hyperplasia with atypia (EHA) but limited evidence is available on its effectiveness.
Oehler, MK, Leung, Y, Cummings, M, Sykes, P, Alizart, M, Garrett, A, Tang, A, Gebski, V, McNally, O, Walker, G, Janda, M, Armes, JE, Robledo, KP, Chen, C, et al.   +14 more
core   +1 more source

Neoadjuvant Chemotherapy in Luminal A Breast Carcinoma: Histopathological Evidence of Limited Impact

The Egyptian Journal of Histology
Introduction. Breast cancer is the most frequently diagnosed malignancy among women worldwide, including in Saudi Arabia. Aim of work: This retrospective study evaluated the histopathological alterations in luminal A breast carcinomas following ...
Elham Saad, Muhammad Atteya, Ahmed El Fouhil, Eman Elkordy, Rasha Salih, Raeesa Mohammed, Maha Arafah   +6 more
doaj   +1 more source

Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer [PDF]

, 2014
Complete pathological response occurs in 10-20% of patients with rectal cancer who are treated with neoadjuvant chemoradiation therapy prior to pelvic surgery.
Theodoros Thomopoulos, Thomopoulos, Theodoros, Toso, Christian, Mentha, Gilles, Gilles Mentha, Naiken, Surennaidoo, Pascal Gervaz, Rubbia-Brandt, Laura, Surennaidoo P Naiken, Gervaz, Pascal, Morel, Philippe, Christian Toso, Arnaud Roth, Philippe Morel, Roth, Arnaud, Laura Rubbia-Brandt   +15 more
core   +2 more sources

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer [PDF]

Gastroenterology Report, 2015
The management of rectal cancer has evolved significantly in the last few decades. Significant improvements in local disease control were achieved in the 1990s, with the introduction of total mesorectal excision and neoadjuvant radiotherapy. Level 1 evidence has shown that, with neoadjuvant chemoradiation therapy (CRT) the rates of local recurrence can
Ferrari, Linda, Fichera, Alessandro
openaire   +2 more sources

Ovarian Sex Cord Stromal Tumors in Children and Adolescents—The European Standard Clinical Practice Recommendations

Pediatric Blood &Cancer, EarlyView.
ABSTRACT As part of the European Cooperative Study Group for Paediatric Rare Tumours initiative, we developed standard clinical practice guidelines for ovarian sex cord stromal tumors, based on comprehensive national and international cohort analyses, literature review, and a final expert consensus conference.
Dominik T. Schneider, Kris‐Ann Schultz, Nora Schnitzler, Michael Abele, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Ines B. Brecht, Maja Cesen, Andrea Ferrari, Michaela Kuhlen, Malgorzata A. Krawczyk, Ricardo Lopez‐Almaraz, Yves Reguerre, Calogero Virgone, Daniel Orbach   +15 more
wiley   +1 more source

Pathologic complete response is not equivalent to cure in esophageal cancer

Journal of Thoracic Disease, 2019
We thank the authors of the editorial commentary entitled “ Recurrence in complete responders after trimodality therapy in esophageal cancer ”, for their thoughtful review and critical appraisal of our manuscript. Our study examined recurrence in patients with esophageal cancer (EC) that achieved pathologic complete response (pCR) following trimodality
Rebecca, Carr, Daniela, Molena
openaire   +2 more sources